US equities |
NVDA $181.60 ▼-9.26% MU $656.39 ▼-17.46% AMD $404.40 ▼-17.26% TSLA $343.69 ▼-10.77% AAPL $344.17 ▼-1.53% SNDK $806.43 ▼-22.26% MSFT $535.93 ▼-3.58% AMZN $260.21 ▼-2.19%
FinancialContent

Articles published by Retension Pharmaceuticals

News headline image
Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
From Retension Pharmaceuticals
Via GlobeNewswire
Tickers RTSN
News headline image
Retension Pharmaceuticals Announces Pricing of Initial Public Offering
From Retension Pharmaceuticals
Via GlobeNewswire
News headline image
Retension Pharmaceuticals Appoints Alison Schecter, M.D., as Chief Medical Officer and Alex Schwartz as Chief Financial Officer
From Retension Pharmaceuticals
Via Business Wire
News headline image
Retension Pharmaceuticals Announces Completion of Series B Financing to Advance Phase 2b Trial for Uncontrolled and Resistant Hypertension and Issuance of a New U.S. Patent Covering its Lead Candidate, RTN-001
From Retension Pharmaceuticals
Via Business Wire